Home » Beiträge » 10090

View Beitrag #10090

ID	10090
Ident	Banner Beratungswissen Zoanne Mylan/Viatris (Dialog 77)
Titel	Bioidentisches Estradiol (E2) + Nomegestrolacetat
Balkentitel	DAP BERATUNGSWISSEN
Created	2023-10-30 12:46:49
Veraltet	0
typ_id	Universal 2023
sub_typ_id	Banner
html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/beratung/beratungswissen/estradiol-und-nomegestrolacetat/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Beratungswissen_Bioidentisches-Estradiol-und-Nomegestrolacetat.jpg" alt="DAP Beratungswissen Bioidentisches Estradiol (E2) + Nomegestrolacetat" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP Beratungswissen Bioidentisches Estradiol (E2) + Nomegestrolacetat"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>
Typo3Html	<table class="es-content" cellspacing="0" cellpadding="0" align="center" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;width:100%;table-layout:fixed !important"> <tbody> <tr> <td align="center" style="padding:0;Margin:0"> <table style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px;background-color:transparent;width:700px" cellspacing="0" cellpadding="0" align="center"> <tbody> <tr> <td align="left" style="padding:0;Margin:0;padding-right:20px;padding-left:20px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:collapse;border-spacing:0px"> <tbody> <tr> <td valign="top" align="center" style="padding:0;Margin:0;width:660px"> <table width="100%" cellspacing="0" cellpadding="0" style="mso-table-lspace:0pt;mso-table-rspace:0pt;border-collapse:separate;border-spacing:0px;border-radius:0;background-color:#ffffff" bgcolor="#ffffff"> <tbody> <tr> <td align="left" class="adapt-img" style="padding:0;Margin:0;font-size:0"><a target="_blank" href="https://www.deutschesapothekenportal.de/beratung/beratungswissen/estradiol-und-nomegestrolacetat/" style="mso-line-height-rule:exactly;text-decoration:none;font-size:14px;color:#005CA9"><img class="adapt-img" src="https://www.deutschesapothekenportal.de/newsletter/nlbanner/DAP-NL-Banner_Beratungswissen_Bioidentisches-Estradiol-und-Nomegestrolacetat.jpg" alt="DAP Beratungswissen Bioidentisches Estradiol (E2) + Nomegestrolacetat" style="display:block;font-size:14px;border:0;outline:none;text-decoration:none;border-radius:0" title="DAP Beratungswissen Bioidentisches Estradiol (E2) + Nomegestrolacetat"></a></td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table> </td> </tr> </tbody> </table>

Newsletter 2023

2023-10-19 2023-10-27 2023-11-08 2023-11-09 2023-12-19 2023-12-28 2024-01-09 2024-01-25 2024-02-15 2024-02-22 2024-03-25 2024-05-08

Beitrag per e-mail verschicken

Auswertungsvorlage anzeigen

Statistik anzeigen